Regulation of the G(2)/M transition in Xenopus oocytes by the cAMP-dependent protein kinase.
Vertebrate oocytes are arrested in G(2) phase of the cell cycle at the prophase border of meiosis I. Progesterone treatment of Xenopus oocytes releases the G(2) block and promotes entry into the M phases of meiosis I and II. Substantial evidence indicates that the release of the G(2) arrest requires a decrease in cAMP and reduced activity of the cAMP-dependent protein kinase (PKAc). It has been reported and we confirm here that microinjection of either wild type or kinase-dead K72R PKAc inhibits progesterone-dependent release of the G(2) arrest with equal potency and that inhibition can be reversed by a second injection of the heat-stable inhibitor of PKAc, PKI. However, a mutant enzyme predicted to be completely kinase-dead from the crystal structure of PKAc, K72H PKAc, was much less inhibitory when carrying additional mutations that block interaction with either type I or type II regulatory subunit. Moreover, inhibition by K72H PKAc was reversed by PKI at a 30-fold lower concentration and with more rapid kinetics compared with wild type PKAc. K72R PKAc was found to have low but detectable activity after incubation in an oocyte extract. These results indicate that inhibition of the progesterone-dependent G(2)/M transition in oocytes after microinjection of dead PKAc reflects either low residual activity or binding to regulatory subunits with a resulting net increase in the level of endogenous wild type PKAc. Consistent with this hypothesis, the induction of mitosis in Xenopus egg extracts by the addition of cyclin B was blocked by wild type PKAc but not by K72H PKAc. The identification of substrates for PKAc that maintain cell cycle arrest in G(2) remains an important goal for future work.
Eyers
Patrick A
PA
Howard Hughes Medical Institute and Department of Pharmacology, University of Colorado School of Medicine, Denver, Colorado 80262, USA.
Liu
Junjun
J
Hayashi
Nobuhiro R
NR
Lewellyn
Andrea L
AL
Gautier
Jean
J
Maller
James L
JL
D000818:Animals; D002455:Cell Division; D018360:Crystallography, X-Ray; D000242:Cyclic AMP / Q000378:metabolism; D019926:Cyclin B / Q000737:chemistry; D018076:DNA, Complementary / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D016195:G2 Phase; D015971:Gene Expression Regulation, Enzymologic; D007700:Kinetics; D008540:Meiosis; D051379:Mice; D008938:Mitosis; D009865:Oocytes / Q000737:chemistry / Q000378:metabolism*; D011374:Progesterone / Q000378:metabolism; D011485:Protein Binding; D011994:Recombinant Proteins / Q000737:chemistry; D013997:Time Factors; D014982:Xenopus laevis
D019926:Cyclin B; D018076:DNA, Complementary; D011994:Recombinant Proteins; D011374:Progesterone; D000242:Cyclic AMP